Torti Frank bought ROIV
February 19, 2026 · Form 4 insider transaction
Torti Frank bought 1,400,000 shares of Roivant Sciences Ltd. at $3.85 per share, a transaction worth $5.39M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,400,000
Price
$3.85
Total value
$5.39M
InsiderTorti Frank
RoleOfficer
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateFebruary 19, 2026
Filing dateFebruary 23, 2026
Shares owned after15,136,547
OwnershipDirect
10b5-1 planNo
AmendedNo